PK Hocknell,
RD Wiley,
X Wang,
TG Evans,
WJ Bowers,
T Hanke,
HJ Federoff,
S Dewhurst.
(2002)
" Expression of human immunodeficiency virus type 1 gp120 from herpes simplex virus type 1-derived amplicons results in potent, specific, and durable cellular and humoral immune responses.
"
J Virol
76.
5565-80
PMID:
11991985
|
Abstract and Keywords
P Zajac,
D Oertli,
W Marti,
M Adamina,
M Bolli,
U Guller,
C Noppen,
E Padovan,
E Schultz-Thater,
M Heberer,
G Spagnoli.
(2003)
" Phase I/II clinical trial of a nonreplicative vaccinia virus expressing multiple HLA-A0201-restricted tumor-associated epitopes and costimulatory molecules in metastatic melanoma patients.
"
Hum Gene Ther
14.
1497-510
PMID:
14577912
DOI:
10.1089/104303403322495016
|
Abstract and Keywords
R Chavan,
KA Marfatia,
IC An,
DA Garber,
MB Feinberg.
(2006)
" Expression of CCL20 and granulocyte-macrophage colony-stimulating factor, but not Flt3-L, from modified vaccinia virus ankara enhances antiviral cellular and humoral immune responses.
"
J Virol
80.
7676-87
PMID:
16840346
DOI:
10.1128/JVI.02748-05
|
Abstract and Keywords
SW Lin,
AS Cun,
K Harris-McCoy,
HC Ertl.
(2007)
" Intramuscular rather than oral administration of replication-defective adenoviral vaccine vector induces specific CD8+ T cell responses in the gut.
"
Vaccine
25.
2187-93
PMID:
17229501
DOI:
10.1016/j.vaccine.2006.11.044
|
Abstract and Keywords